Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise as much as $940 million as it returns to the stock market.

With Hong Kong's IPO market showing a good recovery in 2024 and more stimulus measures launched by China since September 2024 ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

The Inner Mongolia-based maker of carbonated beverages, juices and protein drinks is working with advisers on the size and ...

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Demand from Hong Kong retail investors was 6,000 times more than the amount of shares allocated to them, the second highest ...

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...